ETF午評 | 創新藥板塊繼續爆發,創新藥ETF天弘、創新藥ETF國泰分別漲4.56%、4.26%
A股三大指數窄幅震盪,截至午間收盤,滬指跌0.08%,深成指跌0.04%,創業板指漲0.92%,北證50指數跌0.04%,滬深京三市成交額11459億元,較上日放量71億元。兩市超3800只個股下跌。 板塊題材上,CRO、 PET銅箔、半導體板塊走高,草甘膦、保險板塊調整。ETF方面,創新藥板塊繼續爆發,創新藥ETF天弘、創新藥ETF國泰、華寶基金港股通創新藥ETF分別漲4.56%、4.26%和3.9%。AI基建板塊延續漲勢,創業板人工智能ETF南方、富國基金通信設備ETF分別漲3.04%和2.94%。歐股下挫,德國DAX指數收跌1.02%。法國CAC-40指數收低0.43%,德國ETF、法國CAC40ETF分別跌2.51%、2.04%。港股科網股下挫,港股互聯網ETF、港股通科技30ETF分別跌1.83%和1.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.